|
|
Article: Ondine Biopharma Announces Third Quarter 2009 Financial Results.(Financial report)
- Article from:
- Marketwire Canada
- Article date:
- November 12, 2009
CopyrightCOPYRIGHT 2009 Canadian Corporate News. News Provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
VANCOUVER, BRITISH COLUMBIA, Nov 12, 2009 (Marketwire via COMTEX) -- Ondine Biopharma Corporation (the "Company" or "Ondine") (TSX:OBP)(AIM:OBP) a medical device company developing photodisinfection based products, today announced its financial results for the third quarter ended September 30, 2009.
"During the third quarter of 2009, we advanced several of our photodynamic product development initiatives, including an innovative cordless laser photodisinfection system with applications in both new medical and existing dental markets," said Carolyn Cross, Ondine's Chairman & CEO. "Subsequent to regulatory approval we expect to supply the new laser to Periowave ...